BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The British Journal of Cardiology - ECPv5.3.1.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The British Journal of Cardiology
X-ORIGINAL-URL:https://bjcardio.co.uk
X-WR-CALDESC:Events for The British Journal of Cardiology
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210115T100000
DTEND;TZID=Europe/London:20210115T120000
DTSTAMP:20210103T174635
CREATED:20201020T160714Z
LAST-MODIFIED:20201020T173104Z
UID:45285-1610704800-1610712000@bjcardio.co.uk
SUMMARY:SGLT2 inhibitors and GLP-1 analogues in the management of type 2 diabetes and cardiorenal disease
DESCRIPTION:A webinar from The Hatter Cardiovascular Institute\, UCL \nRecognising the importance of informing clinical trainees early in their careers\, this is one of a series of meetings created to address this need. \nTrainees (SpR’s) in the specialsites Cardiology\, Nephrology and Diabetes are invited to attend this webinar with leaders in all three fields presenting specific to the topic area in a clinical setting. \nRegister here \nPresentations\n \n1. Management of T2D – out with the old and in with the new!\nProfessor Stephanie Baldeweg – UCL \n2. New anti-diabetic therapy – their role in renal protection\nProfessor David Wheeler – the Royal Free Hospital\, UCL \n3. The GLP-1 analogues – their role in obesity\nProfessor Rachel Batterham – UCL \n4. SGLT2 inhibitors – their role in heart failure\nProfessor Teresa McDonagh – KCL \n5. Protection by SGLT2 inhibitors and GLP-1 analogues – do we understand the mechanisms?\nDr Robert Bell – UCL \nConclusions from SpR’s in each field:\n\nDr Sarah Qian (SpR in Diabetes)\nDr Ali Rauf (SpR in Cardiology)\nDr Tamer Rezk (SpR in Nephrology)\n\nChairs:\n\nProfessor Derek Yellon\nProfessor John Cunningham\nProfessor Stephanie Baldeweg
URL:https://bjcardio.co.uk/event/sglt2-inhibitors-and-glp-1-analogues-in-the-management-of-type-2-diabetes-and-cardiorenal-disease/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210129
DTEND;VALUE=DATE:20210130
DTSTAMP:20210103T174635
CREATED:20201020T172453Z
LAST-MODIFIED:20201020T173201Z
UID:45288-1611878400-1611964799@bjcardio.co.uk
SUMMARY:Cardiovascular SIG meeting 2021
DESCRIPTION:This event is intended for clinicians and healthcare professionals working with older people in acute and community settings. The day will include keynote presentations from experts in the field\, workshops and plenary sessions demonstrating best practice approaches available. We hope you will make contacts and start collaborations which will continue on from this meeting. \nRegistration is open now \nWhy participate:\n\nUnderstand more on the key areas & challenges faced in geriatric medicine\nHear focused presentations on core areas of the geriatric medicine\nPresent the latest scientific research to British Geriatrics Society members and elected officers\nAttend small group workshop sessions\nNetwork & socialise with other healthcare professionals over 3 days\n\nEarly bird registration expires on 29th November\nhttps://www.bgs.org.uk/events/cardiovascular-sig-meeting-2021
URL:https://bjcardio.co.uk/event/cardiovascular-sig-meeting-2021/
END:VEVENT
END:VCALENDAR